U.S. Markets for Skin Replacements and Substitutes and Active Wound Repair Modulators

The scope of this report includes tissue-engineered skin replacements andsubstitutes (i.e., epidermal equivalents, dermal equivalents, and multilayer equivalents) and active wound repair modulators (i.e., growth factors, gene therapy, and other active wound repair modulators and pharmaceuticals such as new classes of antibiotics and anti-infectives, hormones, matrix metalloproteinase enzyme inhibitors, neuropeptides in diabetic wounds, stem cells, and numerous other types of peptides and pharmaceuticals).